TY  - GEN
AU  - Aberg,Judith A
AU  - Tebas,Pablo
AU  - Overton,Edgar Turner
AU  - Gupta,Samir K
AU  - Sax,Paul E
AU  - Landay,Alan
AU  - Falcon,Ron
AU  - Ryan,Robert
AU  - De La Rosa,Guy
TI  - Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks
SN  - 1931-8405
PY  - 2013///0219
KW  - Acquired Immunodeficiency Syndrome
KW  - drug therapy
KW  - Adult
KW  - Aged
KW  - Atazanavir Sulfate
KW  - Biomarkers
KW  - blood
KW  - CD4 Lymphocyte Count
KW  - Darunavir
KW  - Disease Progression
KW  - Drug Administration Schedule
KW  - Drug Resistance, Viral
KW  - Drug Therapy, Combination
KW  - Female
KW  - Glomerular Filtration Rate
KW  - HIV Protease Inhibitors
KW  - administration & dosage
KW  - HIV-1
KW  - drug effects
KW  - Humans
KW  - Insulin Resistance
KW  - Lipids
KW  - Male
KW  - Middle Aged
KW  - Oligopeptides
KW  - Pilot Projects
KW  - Pyridines
KW  - RNA, Viral
KW  - Ritonavir
KW  - Sulfonamides
KW  - Time Factors
KW  - Treatment Outcome
KW  - Viral Load
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1089/aid.2011.0327
ER  -